However, the inhibition of Sox9 could abrogate malignant phenotypes induced by the cocktail of miRNA inhibitors, confirming that SOX9 at least partly modulates the linc-ROR/miRNA axis-mediated acquisition of CSC properties in ESCC. This evidence concerns the gene SOX9 and esophageal squamous cell carcinoma.